Navigation Links
Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma
Date:8/5/2009

RESEARCH TRIANGLE PARK, N.C., Aug. 5 /PRNewswire/ -- Addrenex Pharmaceuticals, a specialty pharmaceutical company dedicated to developing treatments to regulate the adrenergic system, announced today an exclusive partnership with Dream Pharma. In keeping with its long-range plan to advance the treatment of adrenergic-related conditions throughout the world, Addrenex has licensed the right to manufacture, market and sell its lead product, Clonicel, in Korea to Dream Pharma. Dream Pharma is a Division of the Hanwha Group, one of the top 10 business conglomerates in Korea.

Clonicel is being developed for both the treatment of hypertension and attention deficit hyperactivity disorder. Clonicel is a patented extended-release formulation of clonidine hydrochloride, a drug currently approved for hypertension.

"We are very excited to partner with Dream Pharma to bring this important treatment to children struggling with ADHD in Korea," said Steve Butts, Vice President, Commercial Operations at Addrenex Pharmaceuticals. "This agreement is another important milestone for Addrenex as we continue to expand our business activities globally."

This partnership agreement coincides with the 3rd anniversary of the founding of Addrenex. In just three short years, the company has signed several licensing deals with major pharmaceutical companies, advanced four products to various stages of clinical trials and acquired an extensive pipeline of compounds primed for future development. Moving forward, the company will continue to focus on developing treatments for the origin of a wide range of conditions regulated by the adrenergic system. These conditions range from menopausal flushing to insomnia to pain. Currently, these conditions are being managed symptomatically rather than addressing the root cause.

"It is exciting to see so much progress in such a short period of ti
'/>"/>

SOURCE Addrenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... (PRWEB) March 01, 2015 Theme and ... new transition pack for Final Cut Pro ... accordion style transitions to any FCPX editors project.” Said ... our users the tools needed to easily drag and ... The user gets many different controls over the parameters ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 In a ... Fletcher of Game Change Athlete Development ... Leinert about the benefits of athlete development and player ... of the unique challenges that athletes face and how ... future success. , Fletcher became involved in athlete development ...
(Date:2/28/2015)... Morristown, NJ (PRWEB) February 28, 2015 ... Month—is a good time to remind ourselves and ... be ignored, say Atlantic NeuroSurgical Specialists (ANS). , ... (TBI), which account for 75% of TBIs. There ... word concussion may sound benign, but it is ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... 28, 2015 India Network Foundation, ... visitor health insurance programs for visitors coming to the ... elderly parents traveling to the United States are suffering ... and blood pressure. These diseases are so common among ... them as medical conditions. There were 66.8 million cases ...
Breaking Medicine News(10 mins):Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3
... need to improve their infrastructure to prevent and manage outbreaks ... a World Health Organisation (WHO) meeting to chart a roadmap ... ,Dengue is a prevailing disease for the past two ... Pacific. ,The WHO says the frequency of ...
... New light has been shed on proteorhodopsin, the light-sensitive ... the U.S. Department of Energy’s Lawrence// Berkeley National Laboratory ... have demonstrated that when the ability to respire oxygen ... solar power to carry out vital life processes. ...
... vitamin B12, two important nutrients for the development of ... protect cognitive function// among seniors, reports a new epidemiological ... epidemiologist at the USDA HNRCA, "we found a strong ... among people 60 and older who also had adequate ...
... appearing in the February issue of Current Directions in ... mechanisms// to pass on his genes during post-copulation as ... their article, Todd Shackelford and Aaron Getz at Florida ... of males competing for fertilizations." ,For ...
... have solved a decades-old cancer mystery. "We not only ... a master switch for a tumor suppressive network that ... future," said CSHL Associate Professor Alea Mills, Ph.D. The ... issue of Cell. ,Specifically, Mills' discovery identifies ...
... A recent study finds that many seniors are still not ... seem to consume more vitamin K than younger people.,This study ... Metabolic Care. ,Sarah Booth, PhD, lab director of ... Nutrition Research Center on Aging at Tufts University (USDA HNRCA), ...
Cached Medicine News:Health News:WHO Urges Asian Countries To Improve Infrastructure To Tackle Dengue 2Health News:Shedding New Light on Proteorhodopsin 2Health News:Optimum Folate and Vitamin B12 Levels Essential for Cognitive Function in Seniors 2Health News:Males Adapt To Battle With Competing Sperm 2Health News:Scientists Discover New Gene 2Health News:Seniors Not Taking Enough Vitamin K 2
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
(Date:2/26/2015)... -- Today the National Safety Council released a ... effects of pain medications , debunking ... Oxycontin, are safer options than over-the-counter pain relievers. ... on heroin and cocaine combined," said Deborah A.P. ... medications are marketed as the Cadillac option for treating ...
(Date:2/26/2015)... , Feb. 26, 2015 Every year many ... to fight heart disease.  Nevertheless, year after year doctors ... (EKG) as the first test to determine the status ... chest pain or not, even though that technology is ... the fact that doctors know, (while most patients do ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2National Heart Health Month In February 2
... , SAN MATEO, Calif., Oct. 20 AlphaDetail, an ... two new features to its suite of tracking services: ... their competitive landscape by integrating secondary research with tracking ... today is managing through vast amounts of data, gathered ...
... 20 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... Investor Conference on Monday, October 26, 2009 at 5:00 p.m. ... at the Hyatt Regency La Jolla Hotel in San Diego. ... Anadys, will provide an overview of Anadys and its clinical ...
Cached Medicine Technology:AlphaDetail Tracking Study Enhancements: The Advantage of Integration and Speed 2Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... Are offered as either EDTA ... binds the calcium ions and therefore ... and thrombocytes in an EDTA anticoagulated ... to 24 hours. EDTA tubes are ...
... is the most powerful, ... Easy-to-use and rich in ... with a comprehensive authoring ... delivering custom interactive multimedia ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
Medicine Products: